225.71
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Biogen Inc Azioni (BIIB) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
8.70%
2,477.80
|
2,279.40 | 2,534.70 | 2,645.50 | 2,431.00 |
| Cost Of Revenue |
33.40%
661.00
|
495.50 | 674.40 | 605.00 | 629.30 |
| Selling, General, and Administrative |
607.30
|
- | - | - | - |
| Interest Income/Expense |
0.15%
67.60
|
67.50 | 67.40 | 72.60 | 60.00 |
| Costs And Expenses |
10.08%
2,100.10
|
2,335.40 | 1,977.40 | 1,901.50 | 2,119.80 |
| Income/Loss From Continuing Operations Before Tax |
774.46%
377.70
|
-56.00 | 557.30 | 744.00 | 311.20 |
| Income Tax Expense/Benefit, Current |
58.20
|
- | - | - | 70.70 |
| Income Tax Expense/Benefit, Deferred |
85.86%
23.60
|
166.90 | 253.80 | -31.30 | -27.80 |
| Income Tax Expense/Benefit |
919.72%
58.20
|
-7.10 | 90.80 | 109.20 | 70.70 |
| Net Income/Loss |
753.37%
319.50
|
-48.90 | 466.50 | 634.80 | 240.50 |
| Basic Average Shares |
147.10K%
147.20
|
0.10 | 146.60 | 146.50 | 146.10 |
| Diluted Average Shares |
49,367%
148.40
|
0.30 | 147.10 | 146.70 | 146.60 |
| Basic Earnings Per Share |
757.58%
2.17
|
-0.33 | 3.18 | 4.33 | 1.65 |
| Diluted Earnings Per Share |
714.29%
2.15
|
-0.35 | 3.17 | 4.33 | 1.64 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):